Cardiff Oncology, Inc. — Director's Dealing 2021

Sep 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cardiff Oncology, Inc. (CRDF)
CIK: 0001213037
Period of Report: 2021-09-10

Reporting Person: Levine James E. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-10	Common Stock	P	5000	$6.62	Acquired	5000	Direct
2021-09-10	Common Stock	P	5000	$6.75	Acquired	10000	Direct
2021-09-10	Common Stock	P	10000	$6.38	Acquired	20000	Direct
2021-09-10	Common Stock	P	5000	$6.35	Acquired	25000	Direct
2021-09-10	Common Stock	P	5000	$6.32	Acquired	30000	Direct